Company Description
Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.
It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues.
The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.
| Country | United Kingdom |
| Founded | 2022 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 25,408 |
| CEO | Brian James McNamara |
Contact Details
Address: Building 5, First Floor, The Heights Weybridge, X0 KT13 0NY United Kingdom | |
| Phone | 44 1932 822000 |
| Website | haleon.com |
Stock Details
| Ticker Symbol | HLN |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001900304 |
| CUSIP Number | 405552100 |
| ISIN Number | US4055521003 |
| SIC Code | 2844 |
Key Executives
| Name | Position |
|---|---|
| Brian James McNamara | Chief Executive Officer and Executive Director |
| Tobias Hannes Hestler | Chief Financial Officer and Executive Director |
| Sonya Ghobrial | Head of Investor Relations |
| Bjarne Philip Tellmann | General Counsel |
| Tamara Rogers | Chief Marketing Officer |
| Mairead Nayager | Chief Human Resources Officer |
| Filippo Lanzi | President of EMEA and LatAm |
| Keith Choy | President of Asia Pacific |
| Lisa Paley | President of North America |
| Franck Riot | Chief Research & Development Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 24, 2024 | 6-K | Report of foreign issuer |
| Apr 12, 2024 | 6-K | Report of foreign issuer |
| Apr 3, 2024 | 6-K | Report of foreign issuer |
| Apr 2, 2024 | 6-K | Report of foreign issuer |
| Mar 25, 2024 | 25-NSE | Filing |
| Mar 22, 2024 | SC 13D/A | [Amend] General statement of acquisition of beneficial ownership |
| Mar 22, 2024 | 6-K | Report of foreign issuer |
| Mar 21, 2024 | 6-K | Report of foreign issuer |
| Mar 21, 2024 | 6-K | Report of foreign issuer |
| Mar 21, 2024 | 6-K | Report of foreign issuer |